Future Activity Anticipated
By 2006, the World Health Organization estimated there were more than 40 million people around the world living with HIV/AIDS, 25 million of which are using a daily drug therapy pioneered by the Emory researchers.
Emory University continues to be a recognized leader in worldwide HIV/AIDS research, with more than 100 faculty members drawn from diverse departments contributing to Emory's Center for AIDS Research. The large financial reward reaped by Emory and the inventors has been reinvested in a large part, by all parties, into HIV/AIDS research.
- Emory invested in a Global Health Institute, a new chemistry building, additional lab space, science programs for undergraduates, scholarships for science majors and additional faculty.
- Dr. Liotta has formed iThemba, from the Zulu word "hope", a drug discovery company based in South Africa, which he says is a "natural hotbed for AIDS research".
- Dr. Schinazi serves as director of the Virology/Drug Discovery Core at Emory's Center for AIDS Research (CFAR) where he oversees over 100 researchers working toward both a cure and preventative measures for HIV/AIDS.
Both Dr. Liotta and Dr. Schinazi still serve as professors and researchers at Emory University.
|
